Data Snapshot: Oct 05, 2026
<$50K

Sep-2026

Sales

Growth

Trend

6-Month

6

Product Count

SKUs

$32.85

Avg Price

30.9%

YoY Sales Change

-30.6%

YoY Price Change

Canna Clinicals

Where to Buy

Canna Clinicals is stocked at 11 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Buffalo, Canandaigua, and Farmingdale. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/12298.json?v=20261004
Canna Clinicals Sales

Market Insights Snapshot

Canna Clinicals Historical Sales by Category

Canna Clinicals concentrated 82.61% of September 2026 sales in Tincture & Sublingual, where year-over-year sales rose 24.85% but month-over-month fell 16.17%, while Capsules held 8.31% share with a -18.75% YoY and -20.84% MoM slide and Topical represented 9.08% share with a -29.64% MoM decline; the brand-wide average price dropped 30.56% YoY to $32.85, contrasting with Tincture & Sublingual’s higher $34.12 and Capsules’ lower $20.97. In New York Tincture & Sublingual, the brand sat at rank 6, indicating a concentration strategy anchored in a single category that is gaining share year-over-year but encountering short-term pullback month-over-month, implying reliance on a high-price anchor amid broad discounting pressure.

The mix shift suggests pricing is the primary lever: a 30.56% YoY reduction in average price alongside 30.90% brand sales growth indicates elasticity capture in Tincture & Sublingual, while double-digit MoM declines of -16.17% in Tincture & Sublingual and -20.84% in Capsules imply recent promotions may be saturating, not expanding, demand. Holding 82.61% in one category with a rank of 6 in New York positions Canna Clinicals to defend a mid-tier slot, but the -29.64% MoM in Topical and persistent Capsules contraction point to limited diversification, implying the brand’s near-term positioning hinges on stabilizing Tincture & Sublingual velocity rather than broadening into slower-turning formats.

Sep-2026 Rank
Tincture & Sublingual
6
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
82.6%
$34.12
+24.9%
-16.2%
Topical
9.1%
$40.07
—
-29.6%
Capsules
8.3%
$20.97
-18.7%
-20.8%
Canna Clinicals

Competitive Landscape

Canna Clinicals sits at rank #6 in New York Tincture & Sublingual for September 2026, a 3-position climb from #9 year over year, and a 2-position improvement from #8 in June 2026, marking its peak rank to date at #6 in September 2026. In contrast, Mfny (Marijuana Farms New York) slid from #3 to #4 while its sales fell 26.5% year over year, and Veterans Choice Creations (VCC) advanced from #4 to #3 with a 10.5% sales increase, indicating that Canna Clinicals’ upward rank despite mixed competitor movements signals share capture from mid-tier rivals rather than pressure on the entrenched leaders.

Canna Clinicals market ranking for NY Tincture & Sublingual

Canna Clinicals

Notable Products

CBD/THC 1:1 Soothe Cream (1000mg CBD, 1000mg THC) posted the steepest decline at -29.6% while holding rank 5, signaling erosion in Topical traction even as the leading CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml) fell -19.1% at rank 1. Tincture & Sublingual accounts for three of the top four ranks (positions 1, 2, and 4), but the category split widened as CBD/CBN/THC 2:2:1 Sleep Tincture (300mg CBD, 300mg CBN, 150mg THC) rose +26.3% at rank 2 while CBD/THC Unwind Tincture (1050mg CBD, 90mg THC, 15ml) dropped -22.9% at rank 4. The Capsules segment bifurcated with CBD/THC 1:1 Max Strength Capsules 10-Pack (100mg CBD, 100mg THC) sliding -21.1% at rank 3 and the Relief Complex 20-Pack edging +4.9% at rank 6, concentrating volume among a few SKUs with mixed momentum. Overall, the pattern points to a pivot toward sleep and high-THC tincture leadership, while Topical and broad Capsules require repositioning to avoid over-reliance on a single high-volume tincture that still brought in $25,302 in September 2026.

Product
Category
May-2026
Jun-2026
Jul-2026
Aug-2026
Sep-2026
MoM %
CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml)
Tincture & Sublingual
1
1
1
1
1
-19.1%
CBD/CBN/THC 2:2:1 Sleep Tincture (300mg CBD, 300mg CBN, 150mg THC)
Tincture & Sublingual
3
3
4
2
2
+26.3%
CBD/THC 1:1 Max Strength Capsules 10-Pack (100mg CBD, 100mg THC)
Capsules
4
2
3
3
3
-21.1%
CBD/THC Unwind Tincture (1050mg CBD, 90mg THC, 15ml)
Tincture & Sublingual
2
4
2
4
4
-22.9%
CBD/THC 1:1 Soothe Cream (1000mg CBD, 1000mg THC)
Topical
6
>10
5
5
5
-29.6%
CBD/THC/CBG1:1:1 Relief Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBG)
Capsules
8
5
7
7
6
+4.9%
CBD/THC 5:1 Balance Tincture (100mg CBD, 500mg THC)
Tincture & Sublingual
5
>10
6
6
>10
—
CBD/THC/CBN 1:1:1 Sleep Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBN)
Capsules
7
6
>10
>10
>10
—
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market